infections and vaccines in pregnancy

in review 3 min read Updated 2026-10-15
infections and vaccines in pregnancy

Pregnancy physiology (↑HR, ↓BP, ↑WBC, ↑RR) masks sepsis until late — use obstetric-adjusted triggers and trend lactate. Antibiotics within 1 h if shock or sepsis likely, source control (including uterine evacuation) — don’t delay for foetal assessment. Treat asymptomatic bacteriuria. Treat influenza empirically with oseltamivir. Inactivated vaccines (influenza, COVID, Tdap, RSV) are recommended; live vaccines are not.

maternal sepsis

  • Sources: pyelonephritis, chorioamnionitis/endometritis, wound, pneumonia, septic abortion, biliary, mastitis; GAS and E. coli cause most deaths
  • Red flags: SBP <90, HR >120, RR >25, SpO₂ <95%, altered mentation, lactate >2, oliguria — normal WBC in pregnancy up to ~13–15 (higher in labour)
  • Bundle: cultures (blood, urine, genital, wound) → broad IV antibiotics within 1 h (shock/probable sepsis) → ≥30 mL/kg crystalloid within 3 h if hypoperfusion, in 250–500 mL boluses with reassessment (preeclampsia, ↓ oncotic pressure → pulmonary oedema) → norepinephrine for persistent hypotension → source control
  • Empiric: piperacillin–tazobactam ± vancomycin; add clindamycin if GAS/toxic shock suspected; ampicillin covers Listeria
  • Left lateral tilt; VTE prophylaxis; foetal monitoring once mother stable — foetal distress usually resolves with maternal resuscitation

urinary tract

  • Asymptomatic bacteriuria: screen once (urine culture, ~12–16 wk); treat 5–7 d → ↓ pyelonephritis, preterm birth, LBW; test of cure
    • cephalexin, amoxicillin (if susceptible), nitrofurantoin (avoid ≥36–38 wk — neonatal haemolysis), fosfomycin
  • Pyelonephritis: admit; ceftriaxone 1–2 g IV daily → oral (cephalexin/amoxicillin-clavulanate per culture) for 10–14 d total; ~20% develop ARDS/sepsis/preterm labour; suppressive nitrofurantoin/cephalexin after recurrence
  • Avoid fluoroquinolones and TMP-SMX (T1 folate antagonism; late T3 kernicterus) unless no alternative — see urinary tract infections

respiratory

  • CAP: β-lactam (ceftriaxone/amoxicillin) + azithromycin; avoid doxycycline; FQ only if no alternative — see community-acquired pneumonia
  • Influenza: high risk for severe disease (esp. T3, postpartum ≤2 wk) → oseltamivir 75 mg BID × 5 d on suspicion, regardless of symptom duration; post-exposure prophylaxis 75 mg daily × 10 d
  • COVID-19: standard treatment; nirmatrelvir–ritonavir if criteria met; if steroids indicated use prednisolone/methylprednisolone (dexamethasone crosses placenta — use only when foetal lung maturation also indicated); VTE prophylaxis — see influenza and COVID-19

specific infections

infectionpregnancy point
HSVprimary infection in T3 → highest neonatal risk; acyclovir/valacyclovir suppression from 36 wk if recurrent; active lesions in labour → CS
Listeriafebrile illness ± GI symptoms, meningitis; blood cultures; ampicillin (cephalosporins don’t cover)
syphilisscreen T1, 28 wk, delivery in high-prevalence areas; penicillin only — desensitise if allergic; Jarisch–Herxheimer can trigger preterm labour — see syphilis
HIVstart/continue ART immediately; VL near delivery; IV zidovudine + CS if VL >1000 copies/mL; infant prophylaxis; breastfeeding: formula recommended in Canada, shared decision if fully suppressed — see HIV: diagnosis, ART, and prevention
HBV / HCVsee liver and GI disease in pregnancy
GBSrectovaginal screen 35–37 wk; intrapartum penicillin — obstetric
toxoplasmosis, CMV, parvovirus B19, rubella, varicellaserology if exposure/rash; VZIG within 10 d for non-immune exposure; varicella pneumonia → IV acyclovir

vaccines

recommended in pregnancytiming
inactivated influenzaany trimester, every season
COVID-19 mRNAany trimester per NACI
Tdapevery pregnancy, ideally 27–32 wk (13–26 wk if ↑ preterm risk; any time until delivery if missed)
RSV (RSVpreF)28–36 wk, if infant won’t receive nirsevimab — provincial programmes usually fund one strategy
as indicatedHBV, HAV, pneumococcal, meningococcal; rabies PEP if exposed
  • Contraindicated (live): MMR, varicella, LAIV, yellow fever (unless travel unavoidable), oral typhoid → delay conception 4 wk after
  • HPV (9vHPV): can be offered in pregnancy (NACI) — no ↑ adverse pregnancy or foetal outcomes
  • Postpartum: MMR/varicella for non-immune — compatible with breastfeeding; all vaccines compatible with breastfeeding

Prepared 2026-10-15. Not yet verified — check every number against the sources.

Key references

Suggest a correction infections and vaccines in pregnancy